X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB SHASUN PHARMA UNICHEM LAB/
SHASUN PHARMA
 
P/E (TTM) x 23.9 123.9 19.3% View Chart
P/BV x 2.3 8.5 26.5% View Chart
Dividend Yield % 1.1 0.2 485.7%  

Financials

 UNICHEM LAB   SHASUN PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-17
SHASUN PHARMA
Mar-14
UNICHEM LAB/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs32094 339.6%   
Low Rs22146 484.6%   
Sales per share (Unadj.) Rs167.2214.2 78.1%  
Earnings per share (Unadj.) Rs12.05.3 224.1%  
Cash flow per share (Unadj.) Rs16.915.8 107.0%  
Dividends per share (Unadj.) Rs3.001.00 300.0%  
Dividend yield (eoy) %1.11.4 77.5%  
Book value per share (Unadj.) Rs117.053.3 219.4%  
Shares outstanding (eoy) m90.8856.62 160.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.60.3 495.6%   
Avg P/E ratio x22.613.1 172.6%  
P/CF ratio (eoy) x16.04.4 361.5%  
Price / Book Value ratio x2.31.3 176.3%  
Dividend payout %25.118.7 133.9%   
Avg Mkt Cap Rs m24,5783,958 621.0%   
No. of employees `0005.2NA-   
Total wages/salary Rs m2,4872,164 115.0%   
Avg. sales/employee Rs Th2,928.3NM-  
Avg. wages/employee Rs Th479.4NM-  
Avg. net profit/employee Rs Th209.4NM-  
INCOME DATA
Net Sales Rs m15,19512,127 125.3%  
Other income Rs m110229 48.0%   
Total revenues Rs m15,30512,356 123.9%   
Gross profit Rs m1,7881,009 177.2%  
Depreciation Rs m452594 76.1%   
Interest Rs m34415 8.1%   
Profit before tax Rs m1,413230 615.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m326-73 -448.0%   
Profit after tax Rs m1,087302 359.7%  
Gross profit margin %11.88.3 141.4%  
Effective tax rate %23.1-31.7 -72.9%   
Net profit margin %7.22.5 287.1%  
BALANCE SHEET DATA
Current assets Rs m6,4266,884 93.3%   
Current liabilities Rs m3,9178,456 46.3%   
Net working cap to sales %16.5-13.0 -127.4%  
Current ratio x1.60.8 201.5%  
Inventory Days Days6862 109.8%  
Debtors Days Days77108 71.6%  
Net fixed assets Rs m7,4104,970 149.1%   
Share capital Rs m182113 160.5%   
"Free" reserves Rs m10,4542,875 363.6%   
Net worth Rs m10,6363,020 352.2%   
Long term debt Rs m41,817 0.2%   
Total assets Rs m15,25813,347 114.3%  
Interest coverage x42.91.6 2,762.8%   
Debt to equity ratio x00.6 0.1%  
Sales to assets ratio x1.00.9 109.6%   
Return on assets %7.35.4 136.7%  
Return on equity %10.210.0 102.1%  
Return on capital %13.613.3 102.0%  
Exports to sales %24.146.4 52.0%   
Imports to sales %4.914.2 34.7%   
Exports (fob) Rs m3,6665,622 65.2%   
Imports (cif) Rs m7521,728 43.5%   
Fx inflow Rs m5,2985,843 90.7%   
Fx outflow Rs m02,173 0.0%   
Net fx Rs m5,2983,669 144.4%   
CASH FLOW
From Operations Rs m683398 171.9%  
From Investments Rs m-1,316-1,635 80.5%  
From Financial Activity Rs m5921,309 45.3%  
Net Cashflow Rs m-4071 -56.0%  

Share Holding

Indian Promoters % 50.1 39.2 127.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 3.6 419.4%  
FIIs % 3.0 17.6 17.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 39.6 80.1%  
Shareholders   20,176 20,750 97.2%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  AJANTA PHARMA  TTK HEALTHCARE  ORCHID PHARMA LTD  

Compare UNICHEM LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Extends Losses; Pharma Stocks Top Losers(Closing)

After opening the day in red share markets in India witnessed negative trading activity throughout the day, and ended well below the dotted line.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


May 21, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS